Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan—An International CEBCC Study from Poland, the Czech Republic and Slovakia
Renata Pacholczak-Madej, Mirosława Püsküllüoğlu, Anna Polakiewicz-Gilowska, Małgorzata Pieniążek et autres
0 citationsOncology Research Featuring Preclinical and Clinical Cancer Therapeutics